Assessment of primary skin irritability, accumulation and awareness of a health product (moisturizing cream for Psoriasis) through the Patch Test

TCI BIOTECNOLOGIA LTDA0 sitesSeptember 16, 2021

ConditionsPsoriasis

Overview

No summary available.

Registry

who.int

Start Date

September 16, 2021

End Date

November 30, 2021

Last Updated

2 years ago

Study Type

Observational

Sponsor

TCI BIOTECNOLOGIA LTDA

•Male and female; Age: 18 to 59 years; Phototype: I to IV; Whole skin of the area;

•Participants who refuse to participate in the study; Skin marks in the experimental area that interfere in the evaluation of possible skin reactions; Active dermatoses (local and disseminated) that may interfere with the results of the study; Pregnant or lactating women; Historic of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines; Volunteers with a history of allergy to the material used in the study; Background of atopy; Use of vaginal cream; Participants with a history of allergy to products in the tested category; Recent gynecological surgeries; Discharges; History of pathologies aggravated or triggered by ultraviolet radiation; Immunodeficiency sufferers; Kidney, heart or liver transplantation; Forecast of intense sun exposure or tanning session during the period of the study; Forecast of bathing in the sea, pool or sauna during the study; Participants who practice water sports; Use of the following medications for systemic topical use: immunosuppressants, antihistamines, non\-hormonal anti\-inflammatory drugs, and corticosteroids up to two weeks before selection; Treatment with acidic vitamin A and / or its derivatives orally or topically up to 01 month before the beginning of the study; Vaccination forecast during the study or up to 03 weeks before the study; Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study.